Reported 4 months ago
Motley Fool contributors recommend investing in AbbVie, AstraZeneca, and Vertex Pharmaceuticals in June. AbbVie's diverse appeal, high dividends, and growth potential make it attractive. AstraZeneca offers growth opportunities with a plan to increase revenue to $80 billion by the end of the decade and develop new medicines. Vertex Pharmaceuticals, known for its innovative therapies and recent approvals like Casgevy, has a promising pipeline and strong growth prospects. The three stocks present compelling investment opportunities for June.
Source: YAHOO